LVJ-23561-67604
2 vaccinations
3 coded responses
16 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 305 / GA
- Registered
- 2021-10-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-27
Dose 1 — Janssen/Johnson & Johnson
-
2021-10-29
Registered in v-safe
-
2021-10-29
Dose 2 — Pfizer-BioNTech
- 2021-10-29
-
2021-10-30
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Itching · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-10-31
-
2021-11-01
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Swelling · Fatigue or tirednessAdult check-in
-
2021-11-02
Survey response — days 1–6 daily, dose 2MedDRA: Premature labour — Feeling: Poor · Fatigue or tiredness, Abdominal pain · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Irritable uterine contractions at 28 weeks pregnant.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-02
Report sent to call center — days 1–6 daily, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2021-11-03
-
2021-11-03
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2021-11-04
- 2021-11-05
- 2021-11-12
- 2021-11-19
-
2021-11-26
Survey response — day 28, dose 2MedDRA: Pregnancy — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Swelling during pregnancyMedDRA releases: 2024-11 · check-in free text available
- 2021-12-05
- 2021-12-10
-
2022-01-28
Survey response — 3 months, dose 2MedDRA: Caesarean section, Gestational hypertension, Induced labour — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Induced at 37 weeks 1 day c section due to high blood pressureMedDRA releases: 2024-11 · check-in free text available
-
2022-01-28
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
- 2022-02-01
- 2022-04-29
- 2022-10-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-27 | Janssen/Johnson & Johnson | No |
| 2 | 2021-10-29 | Pfizer-BioNTech | No |
Call center
2 call center cases
1 successful · 1 unsuccessful
Free text
Release 10 — days 1–6 daily, dose 2
Systemic reaction (other): Irritable uterine contractions at 28 weeks pregnant.
Release 10 — day 28, dose 2
Symptoms: Swelling during pregnancy
Release 11 — 3 months, dose 2
Symptoms: Induced at 37 weeks 1 day c section due to high blood pressure
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Caesarean section | · | · | ✓ |
| SD | Gestational hypertension | · | · | ✓ |
| SD | Induced labour | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SRO | Premature labour | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release